Kasra Azarnoush
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kasra Azarnoush has a total of 161 co-authors. Here are the top co-authors by number of shared publications:
Lionel Camilleri
Department of Cardiovascular, University Hospital of Clermont-Ferrand, France
13 shared publications- Bruno Pereira
DRCI, Unité de Biostatistiques, CHU Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France
5 shared publications Etienne Geoffroy
Department of Cardiac Surgery, CHU Gabriel Montpied, 63003 Clermont-Ferrand, France
5 shared publicationsCharles De Riberolles
4 shared publications- Agnès Maurel
Laboratoire d’Hématologie, Centre Hospitalier Universitaire de Toulouse
3 shared publications - Lionel Camilleri
Department of Cardiac Surgery, Gabriel Montpied University Hospital, Clermont-Ferrand, France; ISIT UMR 6284 CNRS, Faculté de médecine, Université d'Auvergne, Clermont-Ferrand, France
3 shared publications
Latest Publications
- 12 October 2023
- Published by Wiley in Transfusion
- Vol. 63 (S5) , 280A-281A
P‐TS‐38 | Impact of Amotosalen/UVA Treatment for Pathogen Reduction in Platelet Concentrates on Transfusion Efficacy in Cardiac Surgery
- 12 October 2023
- Published by Wiley in Transfusion
- Vol. 63 (S5) , 280A-281A
P‐TS‐38 | Impact of Amotosalen/UVA Treatment for Pathogen Reduction in Platelet Concentrates on Transfusion Efficacy in Cardiac Surgery
- Open Access
- 30 January 2021
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 13 (1) , 23-27
Rapid-deployment aortic valve replacement in high-risk patients: A case-control study
Introduction: Aortic valve stenosis is the most frequent cardiac valve pathology in the western world. In high-risk patients, conventional aortic valve replacement (C-AVR) carries high rates of morbidity and mortality. In the last few years, rapid-deployment valves (RDV) have been developed to reduce the surgical risks. In this work, we aimed to compare the mid-term outcomes of rapid-deployment AVR (RD-AVR) with those of the C-AVR in high-risk patients. Methods: This retrospective case-control study identified 23 high-risk patients who underwent RD-AVR between 12/2015 to 01/2018. The study group was compared with a control group of 46 patients who were retrospectively selected from a database of 687 C-AVR patients from 2016 to 2017 which matched with the study group for age and Euro SCORE II. Results: RD-AVR group presented more cardiovascular risk factors. Euro SCORE II was higher in the RD-AVR group (P=0.06). In the RD-AVR group, we observed significantly higher mean prosthetic size (P<0.001). In-hospital mortality was zero in RD-AVR group versus 2 deaths in C-AVR group. Hospital stay was longer in the RD-AVR group with statistical significance (P=0.03). In the group AVR with associated cardiac procedures, while comparing subgroups RD-AVR versus C-AVR, early mean gradient was lower in the first cited (P=0.02). The overall mean follow-up was 10.9 ± 4.3 months. Conclusion: The RD-AVR technique is reliable and lead to positive outcomes. This procedure provides a much larger size with certainly better flow through the aortic root. It is an alternative to C-AVR in patients recognized to be surgically fragile.
- 30 January 2021
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 13 (1) , 23-27
Open AccessRapid-deployment aortic valve replacement in high-risk patients: A case-control study
Introduction: Aortic valve stenosis is the most frequent cardiac valve pathology in the western world. In high-risk patients, conventional aortic valve replacement (C-AVR) carries high rates of morbidity and mortality. In the last few years, rapid-deployment valves (RDV) have been developed to reduce the surgical risks. In this work, we aimed to compare the mid-term outcomes of rapid-deployment AVR (RD-AVR) with those of the C-AVR in high-risk patients. Methods: This retrospective case-control study identified 23 high-risk patients who underwent RD-AVR between 12/2015 to 01/2018. The study group was compared with a control group of 46 patients who were retrospectively selected from a database of 687 C-AVR patients from 2016 to 2017 which matched with the study group for age and Euro SCORE II. Results: RD-AVR group presented more cardiovascular risk factors. Euro SCORE II was higher in the RD-AVR group (P=0.06). In the RD-AVR group, we observed significantly higher mean prosthetic size (P<0.001). In-hospital mortality was zero in RD-AVR group versus 2 deaths in C-AVR group. Hospital stay was longer in the RD-AVR group with statistical significance (P=0.03). In the group AVR with associated cardiac procedures, while comparing subgroups RD-AVR versus C-AVR, early mean gradient was lower in the first cited (P=0.02). The overall mean follow-up was 10.9 ± 4.3 months. Conclusion: The RD-AVR technique is reliable and lead to positive outcomes. This procedure provides a much larger size with certainly better flow through the aortic root. It is an alternative to C-AVR in patients recognized to be surgically fragile.
- Open Access
- 4 November 2019
- Published by MDPI AG in Antioxidants
- Vol. 8 (11) , 526
Dietary EPA Increases Rat Mortality in Diabetes Mellitus, a Phenomenon Which Is Compensated by Green Tea Extract
Diabetes is characterized by a high mortality rate which is often associated with heart failure. Green tea and eicosapentaenoic acid (EPA) are known to lessen some of the harmful impacts of diabetes and to exert cardio-protection. The aim of the study was to determine the effects of EPA, green tea extract (GTE), and a combination of both on the cardiac consequences of diabetes mellitus, induced in Wistar rats by injection of a low dose of streptozotocin (33 mg/kg) combined with a high fat diet. Cardiac mechanical function, coronary reactivity, and parameters of oxidative stress, inflammation, and energy metabolism were evaluated. In the context of diabetes, GTE alone limited several diabetes-related symptoms such as inflammation. It also slightly improved coronary reactivity and considerably enhanced lipid metabolism. EPA alone caused the rapid death of the animals, but this effect was negated by the addition of GTE in the diet. EPA and GTE combined enhanced coronary reactivity considerably more than GTE alone. In a context of significant oxidative stress such as during diabetes mellitus, EPA enrichment constitutes a risk factor for animal survival. It is essential to associate it with the antioxidants contained in GTE in order to decrease mortality rate and preserve cardiac function.
- 4 November 2019
- Published by MDPI AG in Antioxidants
- Vol. 8 (11) , 526
Open AccessDietary EPA Increases Rat Mortality in Diabetes Mellitus, a Phenomenon Which Is Compensated by Green Tea Extract
Diabetes is characterized by a high mortality rate which is often associated with heart failure. Green tea and eicosapentaenoic acid (EPA) are known to lessen some of the harmful impacts of diabetes and to exert cardio-protection. The aim of the study was to determine the effects of EPA, green tea extract (GTE), and a combination of both on the cardiac consequences of diabetes mellitus, induced in Wistar rats by injection of a low dose of streptozotocin (33 mg/kg) combined with a high fat diet. Cardiac mechanical function, coronary reactivity, and parameters of oxidative stress, inflammation, and energy metabolism were evaluated. In the context of diabetes, GTE alone limited several diabetes-related symptoms such as inflammation. It also slightly improved coronary reactivity and considerably enhanced lipid metabolism. EPA alone caused the rapid death of the animals, but this effect was negated by the addition of GTE in the diet. EPA and GTE combined enhanced coronary reactivity considerably more than GTE alone. In a context of significant oxidative stress such as during diabetes mellitus, EPA enrichment constitutes a risk factor for animal survival. It is essential to associate it with the antioxidants contained in GTE in order to decrease mortality rate and preserve cardiac function.
- 14 September 2018
- Published by Bangladesh Academy of Sciences in Cardiovascular Journal
- Vol. 11 (1) , 86-88
Cardiac Lymphoma Revealed by Atrial Mass
Primary cardiac lymphoma (PCL) represents a very exceptional clinical entity whose treatment is based on chemotherapy. In this case report, the authors highlight the key role of cardiac surgery in the diagnosis of PCL in a 66-year-old female patient. She was given chemotherapy and so far was on remission.Cardiovasc. j. 2018; 11(1): 86-88
- 14 September 2018
- Published by Bangladesh Academy of Sciences in Cardiovascular Journal
- Vol. 11 (1) , 86-88
Cardiac Lymphoma Revealed by Atrial Mass
Primary cardiac lymphoma (PCL) represents a very exceptional clinical entity whose treatment is based on chemotherapy. In this case report, the authors highlight the key role of cardiac surgery in the diagnosis of PCL in a 66-year-old female patient. She was given chemotherapy and so far was on remission.Cardiovasc. j. 2018; 11(1): 86-88
- 1 October 2017
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 31 (5) , 1776-1778
Inefficacy of Platelet Transfusion in a Heart Transplant Patient Under Continuous Ticagrelor
- 1 October 2017
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 31 (5) , 1776-1778
Inefficacy of Platelet Transfusion in a Heart Transplant Patient Under Continuous Ticagrelor
- Open Access
- 1 January 2017
- Published by Baishideng Publishing Group Inc. in World Journal of Cardiology
- Vol. 9 (10) , 787-793
Clinical outcomes of tricuspid valve repair accompanying left-sided heart disease
Clinical outcomes of tricuspid valve repair accompanying left-sided heart disease
- 1 January 2017
- Published by Baishideng Publishing Group Inc. in World Journal of Cardiology
- Vol. 9 (10) , 787-793
Open AccessClinical outcomes of tricuspid valve repair accompanying left-sided heart disease
Clinical outcomes of tricuspid valve repair accompanying left-sided heart disease
- 3 May 2016
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 15 (7) , 897-901
Are all heparins safe for on-pump heart surgery?
Background: Intravenous Panpharma heparin® was used in all on-pump cardiac surgery in our heart-surgery department for a short period. This brand of heparin replaced the previous Choay heparin® heparin supplied by the Sanofi-Aventis Laboratory. Unusual postoperative bleedings over this period prompted us to evaluate postoperative hemostasis by comparing these two heparins. Methods: We compared data from patients who had undergone on-pump cardiac surgery during Panpharma heparin® period (group P, 257 patients) to those how received Choay heparin® (group C, 194 patients). Results: Despite group P receiving a significantly lower dose of heparin (mean dose 21,000 IU/CEC) compared to group C (mean dose 22,000 IU/CEC) (p = 0.05), the number of surgical re-explorations needed to perfect postoperative hemostasis was significantly higher for group P (3.5% vs. 0) (p = 0.01). Heparin anti-Xa activity after surgery was higher in group P at postoperative h1 and h12 compared to group C, which explained reoperations for hemostasis. Conclusion: Despite standardization, variations remain regarding anticoagulant activity between different manufacturing processes and heparin preparations. Surgical teams need to be aware that the biological effects of different brands of heparin may not be as expected and could endanger a usually safe procedure, such as cardiac surgery.
- 3 May 2016
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 15 (7) , 897-901
Are all heparins safe for on-pump heart surgery?
Background: Intravenous Panpharma heparin® was used in all on-pump cardiac surgery in our heart-surgery department for a short period. This brand of heparin replaced the previous Choay heparin® heparin supplied by the Sanofi-Aventis Laboratory. Unusual postoperative bleedings over this period prompted us to evaluate postoperative hemostasis by comparing these two heparins. Methods: We compared data from patients who had undergone on-pump cardiac surgery during Panpharma heparin® period (group P, 257 patients) to those how received Choay heparin® (group C, 194 patients). Results: Despite group P receiving a significantly lower dose of heparin (mean dose 21,000 IU/CEC) compared to group C (mean dose 22,000 IU/CEC) (p = 0.05), the number of surgical re-explorations needed to perfect postoperative hemostasis was significantly higher for group P (3.5% vs. 0) (p = 0.01). Heparin anti-Xa activity after surgery was higher in group P at postoperative h1 and h12 compared to group C, which explained reoperations for hemostasis. Conclusion: Despite standardization, variations remain regarding anticoagulant activity between different manufacturing processes and heparin preparations. Surgical teams need to be aware that the biological effects of different brands of heparin may not be as expected and could endanger a usually safe procedure, such as cardiac surgery.
- 1 February 2016
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 65 (1) , 7-14
Impact des techniques interventionnelles dans le traitement de la valvulopathie aortique après revascularisation myocardique chirurgicale préalable
- 1 February 2016
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 65 (1) , 7-14
Impact des techniques interventionnelles dans le traitement de la valvulopathie aortique après revascularisation myocardique chirurgicale préalable
- 10 August 2015
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 72 (3) , 525-537
Long-term abdominal adiposity activates several parameters of cardiac energy function
Abdominal obesity increases the incidence of cardiac events but reduces mortality when one of these events occurs. The phenomenon called obesity paradox might be related to myocardial energetics. This study was aimed at determining whether long-term abdominal adiposity alters cardiac energy function. Two groups of male Wistar rats were fed a standard or a Western-type (WD) diet for 8 months. The ex vivo coronary reactivity and mechanical function as well as the mitochondrial oxidative phosphorylation (mOxPhos) and hydrogen peroxide release (mH2O2r) were determined. Abdominal adiposity was augmented by the WD. This was also the case for the coronary reactivity to acetylcholine, but the rate pressure product remained roughly stable despite a reduction of the left ventricle-developed pressure partly compensated by a slight increase in heart rate. The prolonged WD administration resulted in an improvement of mOxPhos, but the mH2O2r was exaggerated which was confirmed in the whole cell by a reduced aconitase to fumarase ratio. This did not modify the plasma oxidative stress due to an increased plasma antioxidant status. In conclusion, long-term WD administration improved the cardiac fitness and might predispose the organism to the obesity paradox. Conversely, the increased mitochondrial mH2O2r can precipitate the heart toward cardiomyopathy if the WD is maintained for a longer duration.
- 10 August 2015
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 72 (3) , 525-537
Long-term abdominal adiposity activates several parameters of cardiac energy function
Abdominal obesity increases the incidence of cardiac events but reduces mortality when one of these events occurs. The phenomenon called obesity paradox might be related to myocardial energetics. This study was aimed at determining whether long-term abdominal adiposity alters cardiac energy function. Two groups of male Wistar rats were fed a standard or a Western-type (WD) diet for 8 months. The ex vivo coronary reactivity and mechanical function as well as the mitochondrial oxidative phosphorylation (mOxPhos) and hydrogen peroxide release (mH2O2r) were determined. Abdominal adiposity was augmented by the WD. This was also the case for the coronary reactivity to acetylcholine, but the rate pressure product remained roughly stable despite a reduction of the left ventricle-developed pressure partly compensated by a slight increase in heart rate. The prolonged WD administration resulted in an improvement of mOxPhos, but the mH2O2r was exaggerated which was confirmed in the whole cell by a reduced aconitase to fumarase ratio. This did not modify the plasma oxidative stress due to an increased plasma antioxidant status. In conclusion, long-term WD administration improved the cardiac fitness and might predispose the organism to the obesity paradox. Conversely, the increased mitochondrial mH2O2r can precipitate the heart toward cardiomyopathy if the WD is maintained for a longer duration.
- Open Access
- 15 October 2014
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 9 (1) , 166
Severe non-traumatic bleeding events detected by computed tomography: do anticoagulants and antiplatelet agents have a role?
Bleeding is the most common and most serious complication of anticoagulant (AC) and antiplatelet agents (APA) which are increasingly used in every day practice. The aim of this study was to enlist and analyze the most severe bleeding events revealed during computed tomography scanner (CT scan) examinations over a 1-year period at our University Hospital and to evaluate the role of ACs and APAs in their occurrence. This descriptive monocentric retrospective study included all patients who benefited from an emergency CT scan with a diagnosis of severe non-traumatic bleeding. Patients were divided into two groups: those treated with ACs and/or APAs, and those not treated with ACs or APAs. After applying the inclusion criteria, 93 patients were enrolled. Sixty-one patients received an anticoagulant or antiplatelet treatment, and 32 did not receive any AC or APA therapy. Seventy nine percent presented with an intracranial hemorrhage, 17% with a rectus sheath or iliopsoas bleeding or hematoma, and 4% with a quadriceps hematoma. Only patients who received ACs or APAs suffered a muscular hematoma (p 3). In our series, intracranial hemorrhage was preponderant and muscular hematomas occurred exclusively in patients treated with ACs and/or APAs. This study needs to be extended to evaluate the impact of new anticoagulant and antiplatelet agents.
- 15 October 2014
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 9 (1) , 166
Open AccessSevere non-traumatic bleeding events detected by computed tomography: do anticoagulants and antiplatelet agents have a role?
Bleeding is the most common and most serious complication of anticoagulant (AC) and antiplatelet agents (APA) which are increasingly used in every day practice. The aim of this study was to enlist and analyze the most severe bleeding events revealed during computed tomography scanner (CT scan) examinations over a 1-year period at our University Hospital and to evaluate the role of ACs and APAs in their occurrence. This descriptive monocentric retrospective study included all patients who benefited from an emergency CT scan with a diagnosis of severe non-traumatic bleeding. Patients were divided into two groups: those treated with ACs and/or APAs, and those not treated with ACs or APAs. After applying the inclusion criteria, 93 patients were enrolled. Sixty-one patients received an anticoagulant or antiplatelet treatment, and 32 did not receive any AC or APA therapy. Seventy nine percent presented with an intracranial hemorrhage, 17% with a rectus sheath or iliopsoas bleeding or hematoma, and 4% with a quadriceps hematoma. Only patients who received ACs or APAs suffered a muscular hematoma (p 3). In our series, intracranial hemorrhage was preponderant and muscular hematomas occurred exclusively in patients treated with ACs and/or APAs. This study needs to be extended to evaluate the impact of new anticoagulant and antiplatelet agents.